NCT02068443 - Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy | Biotech Hunter

Enrollment

374

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Alogliptin

Alogliptin tablets

DRUG

Metformin hydrochloride

Metformin hydrochloride tablets

DRUG

Metformin hydrochloride Placebo

Metformin hydrochloride placebo-matching tablets

Trial Locations (27)

Unknown

Nagoya

Chiba

Fukuoka

Kitakyushu-shi

Kurume-shi

Aki-gun

Hiroshima

Koga-shi

Mito

Tushiura-shi

Ushiku-shi

Kanazawa

Takamatsu-chi

Sendai

Ohita-shi

Okinawa-shi

Shimajiri-gun

Kashiwara-shi

Osaka

Hiki-gun

Oyama-shi

Shimotsuke-shi

Koutoh-ku

Meguro-ku

Sagae-shi

Yamagata

Yamaguchi